StockData
Amylyx Pharmaceuticals, Inc. logo

Amylyx Pharmaceuticals, Inc. (AMLX) stock

AMLXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$26.62−0.90 (-3.27%)

Close on Nov 18, 2026Market cap $2.97BP/E –Yield –

Amylyx Pharmaceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Amylyx Pharmaceuticals's price to sales ratio was 1.3× on Jan 31, 2025, against 3.7× a year earlier.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Jan 31, 20251.3×−0.0
2024Dec 31, 20241.3×−2.1
2023Dec 29, 20233.4×−218.3
2022Apr 29, 2022221.7×–

More Amylyx Pharmaceuticals figures

See a number that looks wrong?